Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antiphospholipid syndrome.

Massimo Franchini1, Dino Veneri

  • 1Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Piazzale Ludovico Scuro, 37134 Verona, Italy. massimo.franchini@mail.azosp.vr.it

Hematology (Amsterdam, Netherlands)
|August 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An unusual case of sodium citrate-dependent artifactual platelet count.

Interventional medicine & applied science·2022
Same author

Pathogenesis of immune thrombocytopenia in common variable immunodeficiency.

Autoimmunity reviews·2020
Same author

Is triple-positive serology for Epstein-Barr virus (VCA-IgG, VCA-IgM, EBNA-IgG) a specific feature of angioimmunoblastic T-cell lymphoma?

Tumori·2019
Same author

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial.

Haematologica·2019
Same author

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs.

Frontiers in pharmacology·2018
Same author

Primary sphenoid lymphoma: Focus on imaging.

Tumori·2018
Same journal

Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Characterization of a novel α-thalassemia deletion (Dongxing deletion; --<sup>DX</sup>) by CNV-seq in a Chinese female with Hb H disease: a case report.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Distinct clinical, molecular, and treatment response profiles in primary and secondary myelofibrosis: a single-center retrospective study.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

Hematology (Amsterdam, Netherlands)·2026
Same journal

Relationship between major depressive disorder and venous thromboembolism: a five-ancestry genetic analysis.

Hematology (Amsterdam, Netherlands)·2026
See all related articles

Antiphospholipid syndrome (APS) is an autoimmune disorder linked to blood clots and pregnancy issues. This review highlights recent advancements in understanding APS pathophysiology, diagnosis, and treatment strategies.

Area of Science:

  • Autoimmune disorders
  • Immunology
  • Rheumatology

Background:

  • Antiphospholipid syndrome (APS) is an autoimmune condition.
  • It is defined by the presence of antiphospholipid antibodies.
  • APS is associated with thrombosis (blood clots) and obstetric complications.

Purpose of the Study:

  • To review recent progress in understanding Antiphospholipid Syndrome.
  • To summarize key advances in pathophysiology, diagnosis, and treatment.
  • To provide an overview of current knowledge on APS.

Main Methods:

  • Literature review of recent scientific publications.
  • Focus on pathophysiology, diagnostic criteria, and therapeutic options.
  • Synthesis of current understanding and future directions.

Related Experiment Videos

Main Results:

  • Recent advances have shed light on APS mechanisms.
  • Improved diagnostic tools are becoming available.
  • New treatment strategies are emerging.

Conclusions:

  • Despite progress, many aspects of APS require further investigation.
  • Continued research is crucial for better patient outcomes.
  • A comprehensive understanding of APS pathophysiology, diagnosis, and treatment is evolving.